<DOC>
	<DOCNO>NCT01482650</DOCNO>
	<brief_summary>The investigator perform number study novel airway device , include observational study performance new supraglottic airway name Baska mask . In new propose study investigator would like compare directly , randomize clinical trial , device device investigator routinely use - single use laryngeal mask airway - LMA , female patient undergo general anaesthesia . This study determine device performs best , measure key parameter ( insertion success rate , seal pressure , time ease insertion , failure rate , complication etc ) regard performance safety profile Baska mask LMA . The investigator two study hypothesis , namely ( 1 ) non-inferiority first placement attempt success rate Baska v LMA ; ( 2 ) great seal pressure Baska mask v LMA . A number secondary endpoint monitor analyze ( time ease insertion , failure rate , complication etc ) .</brief_summary>
	<brief_title>Comparison BASKA Airway , Novel Supraglottic Device , LMA Airway Low Risk Female Patients</brief_title>
	<detailed_description>Airway management essential component safe efficient provision general anaesthesia . Supraglottic airway device establish place airway management . The Baska mask new supraglottic airway device . It bear many feature industry standard - laryngeal mask airway ( LMA ) , potential improvement : - The cuff pressurize thus reduce risk oropharyngeal tissue damage . - Improved cuff seal inspiratory phase positive pressure ventilation may reduce leak make ventilation efficient . - An improved system drainage oropharyngeal content intend reduce rate lung aspiration . - The Baska mask insert neutral head position thus reduce need neck manipulation . - There integrate bite-block reduce risk patient bite block airway . The result observational study performance Baska mask promise investigator feel randomize comparative study gold standard device , Laryngeal Mask Airway ( LMA ) justify . This study randomize , single blind , control clinical trial . The participant allocate two group , investigator use either single use LMA device Baska mask ( single use ) . Clinical Research Ethics Committee approval obtain . Suitable participant recruit write informed consent screen inclusion exclusion criterion . Standard anaesthetic preassessment anaesthesia provide . Consenting patient randomly allocate either 2 study group . Protocol airway size selection attempt placement follow . The investigator monitor number parameter , include time ease insertion , airway seal pressure , airway leak , complication , haemodynamic ventilatory parameter , ease removal . Follow perform . The investigator two primary hypothesis : 1 . That BASKA mask insertion success rate 20 % less single use LMA device . 2 . That seal pressure BASKA mask 40 % high single use LMA . In addition investigator evaluate number secondary outcome .</detailed_description>
	<criteria>Female Written inform consent ASA 13 No relevant allergy Bodymass index ( BMI ) 2035 Age 1685 Nonurgent surgery plan duration 0.254 hr Inability patient/parent understand consent trial Neck pathology Previous anticipate problem upper airway upper GI tract ( reflux , hiatus hernia , oropharyngeal tumour , upper respiratory tract infection last 10 day ) BMI &gt; 35 Predicted previously document difficult airway Live Pregnancy Increased risk Gastric Aspiration Current participation another Clinical Study</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Baska mask</keyword>
	<keyword>LMA</keyword>
	<keyword>laryngeal mask airway</keyword>
	<keyword>supraglottic airway device</keyword>
</DOC>